• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Horizon Pharma Plc

+ Add to Watchlist

HZNP:US

12.2400 USD 0.3500 2.94%

As of 16:30:00 ET on 10/21/2014.

Snapshot for Horizon Pharma Plc (HZNP)

Open: 12.0100 Day's Range: 11.8900 - 12.2600 Volume: 1,315,717
Previous Close: 11.8900 52wk Range: 3.7000 - 18.3000 1-Yr Rtn: +182.03%

Stock Chart for HZNP

No chart data available.
  • HZNP:US 12.2500
  • 1D
  • 1M
  • 1Y
11.8900
Interactive HZNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HZNP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.2007
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8118
Est. EPS (USD) (12/2014) 0.5980
Est. PEG Ratio -
Market Cap (M USD) 1,285.24
Shares Outstanding (M) 106.13
30 Day Average Volume 1,983,448
Price/Book (mrq) 11.2713
Price/Sale (ttm) 4.8266
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HZNP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HZNP

Horizon Pharma Plc is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation.

Timothy P WalbertChairman/President/CEOPaul W HoelscherExec VP/CFO/Secretary
Robert F Carey "Bob"Exec VP/Chief Business OfficerJeffrey W ShermanExec VP:Research & Development
More Company Profile & Key Executives for HZNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil